128 results
Page 3 of 7
8-K
EX-99.1
u5o9o qdq
3 Feb 21
AbbVie Reports Full-Year and Fourth-Quarter 2020 Financial Results
7:41am
8-K
EX-99.1
dg78yedtgf1
12 Jan 21
Regulation FD Disclosure
4:30pm
8-K
EX-99.1
1gdf0
18 Nov 20
AbbVie Announces Expiration and Final Results of Registered Exchange Offers
5:16pm
8-K
EX-99.1
h0u uxdcis
30 Oct 20
AbbVie Reports Third-Quarter 2020 Financial Results
7:52am
8-K
EX-99.1
tb8pt8iot9ps4oweg
19 Oct 20
AbbVie Announces Commencement of Registered Exchange Offers
9:13am
8-K
EX-99.1
ebf0dq
31 Jul 20
AbbVie Reports Second-Quarter 2020 Financial Results
8:41am
8-K
EX-99.1
3e0qa2bu vz
8 May 20
AbbVie Completes Transformative Acquisition of Allergan
4:31pm
8-K
EX-99.1
j1fmce5 vlivai6hndd6
6 May 20
AbbVie and Allergan Receive Clearance from U.S. Federal Trade Commission for AbbVie’s Acquisition of Allergan
12:00am
8-K
EX-99.1
q1z4q1z8yo
1 May 20
AbbVie Reports First-Quarter 2020 Financial Results
7:44am
8-K
EX-99.1
0jtkzd m96ckf
7 Feb 20
AbbVie Reports Full-Year and Fourth-Quarter 2019 Financial Results
7:48am
8-K
EX-99.1
520pj3 c5p6iryou
13 Nov 19
AbbVie Prices $30 Billion of Senior Unsecured Notes
4:43pm
8-K
EX-99.2
ajggp24 lb
6 Nov 19
Regulation FD Disclosure
3:30pm
8-K
EX-99.1
cox54zce372e8 dxreh
1 Nov 19
AbbVie Reports Third-Quarter 2019 Financial Results
7:50am